With 15 GB on GA II and Avantome Buy, Illumina Confident in Next-Gen Battle | GenomeWeb
Illumina said last week that it saw “continued strong demand” in the second quarter for its Genome Analyzer II, which now generates up to 15 gigabases of data per run at the company.
 
As part of its second-quarter financial report, the company also said that it will acquire Avantome, a privately held company developing a low-cost, long-read sequencing technology (see related article, this issue).
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.